Stockscreener 앱 받기
5.99
2.57%
0.15
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
Fennec Pharmaceuticals (NASDAQ:FENC) Given Outperform Rating at Wedbush - MarketBeat
Fennec Pharmaceuticals Inc. - Baystreet.ca
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - The Manila Times
Fennec's PEDMARQSI® Breakthrough: First NHS Treatment for Child Cancer-Related Hearing Loss - StockTitan
HC Wainwright Issues Negative Forecast for TSE:FRX Earnings - Defense World
What is HC Wainwright’s Forecast for FENC FY2024 Earnings? - Defense World
FY2024 Earnings Estimate for TSE:FRX Issued By HC Wainwright - MarketBeat
HC Wainwright Has Bearish Forecast for FENC FY2024 Earnings - MarketBeat
Fennec Pharmaceuticals partially repays its outstanding convertible debt facility - MSN
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management - The Manila Times
Verition Fund Management LLC Sells 23,113 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals' (FENC) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Sold by BNP Paribas Financial Markets - Defense World
Stocks In Play: Fennec Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Fennec Pharmaceuticals (TSE:FRX) Trading Down 0.3% – Time to Sell? - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Down 0.3%Time to Sell? - MarketBeat
Fennec Pharmaceuticals Inc (FRX-T) QuotePress Release - The Globe and Mail
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference - The Manila Times
Fennec Pharmaceuticals to Present at H.C. Wainwright Fireside Chat Series - StockTitan
Where are the Opportunities in (FENC) - Stock Traders Daily
Fennec Pharmaceuticals director Raykov Rosty sells shares worth $4,807 - Investing.com
Fennec Pharmaceuticals director Raykov Rosty sells shares worth $4,807 By Investing.com - Investing.com Nigeria
Insider Sell: Rosty Raykov Sells Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus.com
Fennec Pharmaceuticals director sells $10,022 in stock By Investing.com - Investing.com UK
Fennec Pharmaceuticals director sells $39,351 in shares By Investing.com - Investing.com Canada
Fennec Pharmaceuticals director sells $39,351 in shares - Investing.com India
Long Term Trading Analysis for (FENC) - Stock Traders Daily
A Data-Based Look At Fennec Pharmaceuticals Inc (FENC) - Stocks Register
Improved Revenues Required Before Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Stock's 25% Jump Looks Justified - Simply Wall St
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2024 - Marketscreener.com
Fennec Pharmaceuticals (NASDAQ:FENC) Upgraded at Stephens - Defense World
Fennec Pharmaceuticals (TSE:FRX) Upgraded at Stephens - Defense World
Fennec Pharmaceuticals (TSE:FRX) Upgraded by Stephens to "Strong-Buy" Rating - MarketBeat
Fennec Pharmaceuticals (NASDAQ:FENC) Upgraded by Stephens to Strong-Buy Rating - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below 50 Day Moving AverageShould You Sell? - MarketBeat
DG Capital Management, LLC Adjusts Stake in Fennec Pharmaceutica - GuruFocus.com
Fennec Pharmaceuticals Drops To US$4.26, Yet Insiders May Have Sold Too Early - Simply Wall St
Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Fennec Pharma stock hits 52-week low at $4.07 amid challenges - Investing.com Australia
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2024 Earnings Call Transcript - Insider Monkey
Wedbush Analysts Decrease Earnings Estimates for FENC - MarketBeat
What is Wedbush's Forecast for TSE:FRX FY2025 Earnings? - MarketBeat
Earnings call: Fennec Pharmaceuticals reports robust Q3 growth By Investing.com - Investing.com Australia
Earnings call: Fennec Pharmaceuticals reports robust Q3 growth - Investing.com
Wedbush Reaffirms “Outperform” Rating for Fennec Pharmaceuticals (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals Inc (FENC) Quarterly 10-Q Report - Quartzy
Fennec Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Fennec Pharma Q3 Sales Rise to $7M, Losses Widen Despite PEDMARK Reimbursement Success | FENC Stock News - StockTitan
Apogee Therapeutics (NASDAQ:APGE) and Fennec Pharmaceuticals (NASDAQ:FENC) Financial Contrast - Defense World
FENCFennec Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan
Insider Sale: Director Rosty Raykov Sells Shares of Fennec Pharm - GuruFocus.com
Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 2,431 Shares of Stock - MarketBeat
Fennec Pharmaceuticals director Raykov Rosty sells $10,477 in stock - Investing.com India
2.88%
2.65%
자본화:
|
볼륨(24시간):